Pilocarpine hydrochloride for the treatment of xerostomia in patients with Sjögren's syndrome in Taiwan--a double-blind, placebo-controlled trial
Journal
Journal of the Formosan Medical Association = Taiwan yi zhi
Journal Volume
105
Journal Issue
10
Pages
796
Date Issued
2006-10
Author(s)
Abstract
Sjögren's syndrome (SS) is characterized by diminished exocrine secretions with the resultant symptoms of dry mouth and dry eye. As genetic predisposition and ethnicity may alter the effectiveness of drug treatment, evaluation of the efficacy and safety of the secretagogue pilocarpine hydrochloride in the treatment of xerostomia in patients with SS in different populations is needed.
Subjects
Pilocarpine | Sjögren's syndrome | Xerostomia
SDGs
Other Subjects
antacid agent; hydroxychloroquine sulfate; nonsteroid antiinflammatory agent; pilocarpine; placebo; prednisolone; adult; aged; article; clinical article; clinical trial; controlled clinical trial; controlled study; disease association; double blind procedure; drug efficacy; drug safety; drug tolerability; female; heart palpitation; human; language ability; male; patient assessment; questionnaire; randomized controlled trial; salivation; Sjoegren syndrome; sleep; sweat gland disease; symptom; Taiwan; visual analog scale; xerostomia
Type
journal article